Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein Barr virus encoded latent membrane protein 1

Science in China, Series C: Life Sciences

Volumn 48, Issue 1, 2005, Pages 70-80

  Song, Xin ^a   Tao, Yongguang ^a   Tan, Yunnian ^a   Lee, Leo M ^b   Deng, Xiyun ^a   Wu, Qiao ^c   Cao, Ya ^a  

^a Central South University   (China)

^b SAIC FREDERICK INC   (United States)

^c XIAMEN UNIVERSITY   (China)

Author keywords

c Jun; DNA binding; Epstein Barr virus; Heterodimer; JIP; JNK; Jun B; Latent membrane protein 1

Indexed keywords

HUMAN HERPESVIRUS 4;

DNA; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CARCINOMA; CELL DIFFERENTIATION; CHEMISTRY; CONFOCAL MICROSCOPY; DIMERIZATION; ELECTROPHORESIS; EPSTEIN BARR VIRUS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; IMMUNOPRECIPITATION; METABOLISM; NASOPHARYNX TUMOR; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; DIMERIZATION; DNA; ELECTROPHORESIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NASOPHARYNGEAL NEOPLASMS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; UP-REGULATION; VIRAL MATRIX PROTEINS;

EID: 21944447247     PISSN: 10069305     EISSN: None     Source Type: Journal    
DOI: 10.1360/03yc0218     Document Type: Article

References (42)

1. Eliopoulos, A. G., Young, L. S., Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1), Oncogene, 1998, 16: 1731-1742.
2. Vogt, P. K., Jun, the oncoprotein, Oncogene, 2001, 20: 2365-2377.
3. Wisdom, R., Johnson, R. S., Moore, C., c-Jun regulates cell cycle progression and apoptosis by distinct mechanism, EMBO J., 1999, 18: 188-197.
4. Smith, L. M., Wise, S. C., Hendricks, D. T. et al., c-Jun overexpression in MCF-7 breast cancer cells produces a tumorigenic invasive and hormone resistant phenotype, Oncogene, 1999, 18: 6063-6070.
5. Wang, N. P., Vema, L., Hardy, S. et al., c-Jun triggers apoptosis in human vascular endothelial cells, Circulation Res., 1999, 85: 387-393.
6. INK4a expression, EMBO J., 2000, 19: 2969-2979.
7. Hulboy, D., Matrisian, L. M., Crawford, H. C., Loss of Jun B activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin rumors, Mol. Cell Biol., 2001, 21: 5478-5487.
8. Baiyong, L., Cathy, T., Roger, J. et al., Regulation of IL-4 expression by the transcription factor Jun B during T helper cell differentiation, EMBO J., 1999, 18: 420-432.
9. Jacobs-Helber, S. M., Abutin, R. M., Tian, C. et al., Role of Jun B in erythroid differentiation, J. Biol. Chem., 2002, 277: 4859-4866.
10. Passegue, E., Jochum, W., Schorpp-Kistner, M. et al., Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking Jun B expression in the myeloid lineage, Cell, 2001, 104: 21-32.
11. Mao, X., Orchard, G., Lillington, D. M. et al., Amplification and overexpression of Jun B is associated with primary cutaneous T-cell lymphomas, Blood, 2003, 101: 1513-1519.
12. Chalaux, E., Lopez-Rovira, T., Rosa, J. L. et al., Jun B is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2, J. Biol. Chem., 1997, 272: 537-543.
13. Robinson, C. M., Prime, S. S., Huntley, S. et al., Overexpression of Jun B in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation, Int. J. Cancer, 2001, 91: 625-630.
14. Szabowski, A., Maas-Szabowski, N., Andrecht, S. et al., c-Jun and Jun B antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin, Cell, 2000, 103: 745-755.
15. Chiu, R., Angel, P., Karin, M., Jun B differs in its biological properties from, and is a negative regulator of c-Jun, Cell, 1989, 59: 979-986.
16. Bakiri, L., Lallemand, D., Ella, B. W. et al., Cell cycle-dependent variations in c-Jun and Jun B phosphorylation: A role in the control of cyclin D1 expression, EMBO J., 2000, 19: 2056-2068.
17. Schlingensiepen, K. H., Schlingensiepen, R., Kunst, M. et al., Opposite functions of Jun B and c-Jun in growth regulation and neuronal differentiation, Dev. Genet., 1993, 14: 305-312.
18. Deng, T., Karin, M., Jun B differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun By formation of inactive heterodimers, Genes Dev., 1993, 7: 479-490.
19. Mathas, S., Hinz, M., Anagnostopoulos, I. et al., Aberrantly expressed c-Jun and Jun B are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B, EMBO J., 2002, 21: 4104-4113.
20. Leaner, V. D., Kinoshita, I., Birrer, M. J., API complexes containing c-Jun and Jun B cause cellular transformation of ratla fibroblasts and share transcriptional targets, Oncogene, 2003, 28: 5619-5629.
21. Liao, W., Yi, H., Cao, Y. et al., Establishment of a Tet-on nasopharyngeal carcinoma cell line regulated by tetracycline and doxycycline, Chinese Journal of Biochemistry and Molecular Biology, 1999, 15: 132-136.
22. Luo, F. J., Peng, X. N., Cao, Y. et al., Epstain-Barr virus LMP1 up regulates activity of AP-1 in nasopharyngeal cell line, Chinese Journal of Biochemistry and Molecular Biology, 2000, 16: 551-555.
23. Tang, F. Q., Tang, M., Cao, Y. et al., Study of apoptosis regulated by Epstein-Barr virus encoded latent membrane protein 1 using apoptosis cDNA expression array, Chinese Journal of Virology, 2001, 17: 97-102.
24. Hu, Z., Tao, Y. G., Cao, Y. et al., Effect of JIP on the proliferation and apoptosis of nasopharyngeal carcinoma cells through interaction with JNK mediated pathway, Progress in Biochemistry and Biophysics, 2003, 30(4): 579-585.
25. Luo, F. J., Hu, Z., Cao, Y. et al., Epstein-Barr virus LMP-1 activated AP-1 mediated by JNK in nasopharyngeal cell line, Chinese Journal of Biochemistry and Molecular Biology, 2001, 17: 381-385.
26. nd ed., New York: Cold Spring Harbor Laboratory Press, 1989.
27. Andrews, N. C., Faller, D. V., A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells, Nucleic Acids Research, 1991, 19: 2499.
28. Ausubel, F. M., Roger, B., Kingston, R. E. et al., Current Protocols in Molecular Biology (Volume 4), New York: John Wiley & Sons Inc. Press.
29. Dickens, M., Rogers, J. S., Cavanagh, J. et al., A cytoplasmic inhibitor of the JNK signal transduction pathway, Science, 1997, 277: 693-676.
30. Chapman, N. R., Perkins, N. D., Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1, J. Biol. Chem., 2000, 275: 4719-4725.
31. Lee, W., Mitchell, P., Tjian, R., Purified transcription factor AP1 interacts with TPA-inducible enhancer elements, Cell, 1987, 49: 741-752.
32. Briggs, M. R., Kadonaga, J. T., Bell, S. P. et al., Purification and biochemical characterization of the promoter-specific transcription factor, Sp1, Science, 1986, 234: 47-52.
33. Vallone, D., Battista, S., Pierantoni, G. M. et al., Neoplastic transformation of rat thyroid cells requires the Jun B and fra-1 gene induction which is dependent on the HMGI-C gene product, EMBO J., 1997, 16: 5310-5321.
34. Gupta, S., Barrett, T., Whitmarsh, A. J. et al., Selective interaction of JNK protein kinase isoforms with transcription factors, EMBO J., 1996, 15: 2760-2770.
35. Kallunki, T., Deng, T., Hibi, M. et al., c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions, Cell, 1996, 87: 929-939.
36. Fuchs, S. Y., Xie, B., Adler, V. et al., C-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors, J. Biol. Chem., 1997, 272: 32163-32168.
37. Wisdom, R., API: One switch for many signals, Exp. Cell Res., 1999, 253(1): 180-185.
38. Behrens, A., Jochum, W., Sibilia, M. et al., Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation, Oncogene, 2000, 19: 2657-2663.
39. Kyriakis, J. M., Avruch, J., pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine, J. Biol. Chem., 1990, 265: 17355-17363.
40. Berry, A., Goodwin, M., Moran, C. L. et al., API activation and altered AP1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells, Biochemical Pharmacology, 2001, 62: 581-591.
41. Hu, Z., Zeng, L., Tao, Y. G. et al., EB virus-encoded latent membrane protein 1 activates the JNK signaling pathway via a mechanism involving TRADD and TRAF in nasopharyngeal carcinoma cell, Prog. Biochem. Biophys., 2002, 29: 562-566.
42. Pulverer, B. J., Kyriakis, J. M., Avruch, J. et al., Phosphorylation of c-Jun mediated by MAP kinases, Nature, 1991, 353: 670-674.